The JNK and p38 MAP kinase signaling pathways in T cell-mediated immune responses

Free Radical Biology and Medicine

Volumn 28, Issue 9, 2000, Pages 1328-1337

  Rincón, Mercedes ^a,d   Flavell, Richard A ^b   Davis, Roger A ^b,c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

Cytokines; Free radical; JNK; MAP kinases; NFAT; P38; T cells; Thymocytes

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; SYNAPTOPHYSIN;

CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS;

EID: 0034190231     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00219-7     Document Type: Article

References (89)

1. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)from inflammation to development. Curr. Opin. Cell. Biol. 10:1998;205-219.
2. Gupta S., Barret T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Dérijard B., Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:1996;2760-2770.
3. Yang D.D., Kuan C.-Y., Whitmarsh A.J., Rincón M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389:1997;865-870.
4. Kuan C.Y., Yang D.D., Samanta Roy D.R., Davis R.J., Rakic P., Flavell R.A. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 22:1999;667-676.
5. Han J., Lee J.-D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
6. Lee J.C., Laydon T., McDonnell P.C., Gallagher T.F., Kumar S., Gree D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., Strickler J.E., McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R., Adams J.L., Young P.R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
7. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
8. Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., Saklatvala J. Interleukin 1 activates a novel protein kinase cascade that results in the phosphorylation of the Hsp27. Cell. 78:1994;1039-1049.
9. Jiang Y., Chen C., Lie Z., Guo W., Gegner J.A., Lin S., Han J. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271:1996;17920-17926.
10. + T cells. Science. 271:1996;1271-1276.
11. Stein B., Brady H., Yang M.X., Young D.B., Barbosa M.S. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade. J. Biol. Chem. 271:1996;11427-11433.
12. Enslen H., Raingeaud J., Davis R.J. Selective activation of p38 MAP kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273:1998;1741-1748.
13. Wang X.S., Diener K., Manthey C.L., Wang S., Rosenzweig B., Bray J., Delaney J., Cole C.N., Chan-Hui P.Y., Mantlo N., Lichenstein H.S., Zukowski M., Yao Z. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;23668-23674.
14. Goedert M., Cuenda A., Craxton M., Jakes R., Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6) comparison of its substrate specificity with that of other SAP kinases . EMBO J. 16:1997;3563-3571.
15. Dérijard B., Rainjeaud J., Barret T., Wu I.-H., Han J., Ulevitch R.J., Davis R.J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;683-685.
16. Sánchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature. 372:1994;794-798.
17. Lin A., Minden A., Martinetto H., Claret F.-X., Lange-Carter C., Mercurio F., Johnson G.L., Karin M. Identification of a dual-specificity kinase that activates the Jun kinases and p38-Mpk2. Science. 268:1995;286-290.
18. 2-terminal kinase. Proc. Natl. Acad. Sci. USA. 94:1997;7337-7342.
19. Han J., Lee J.-D., Jiang Y., Li Z., Feng L., Ulevitch R.J. Characterization of the structure and function of a novel MAP kinases kinases (MKK6). J. Biol. Chem. 271:1996;2886-2891.
20. Moriguchi T., Kuroyanigi N., Yamaguchi K., Gotoh Y., Irie K., Kano T., Shirakabe K., Muro Y., Shibuya H., Matsumoto K., Nishida B., Hagiwara M. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271:1996;13675-13679.
21. Raingeaud J., Whitmarsh A.J., Barret T., Dérijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell Biol. 16:1996;1247-1255.
22. Ganiatsas S., Kwee L., Fujiwara Y., Perkins A., Ikeda T., Labow M.A., Zon L.I. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. USA. 95:1998;6881-6886.
23. Raingeaud J., Gupta S., Roger J., Dickens M., Han J., Ulevitch R.J., Davis R.J. Proinflammatory cytokines and environmental stress cause p38 MAP kinase activation by dual phophorylation on tyrosine and threonine. J. Biol. Chem. 270:1995;7420-7426.
24. Han J., Jian Y., Li Z., Kravchenko V.V., Ulevitch R.J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 386:1997;296-299.
25. Wang X.-Z., Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science. 272:1996;1347-1349.
26. Whitmarsh A.J., Yang S.H., Su M.S., Sharrocks A.D., Davis R.J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:1997;2360-2371.
27. Fukunaga R., Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1997;1921-1933.
28. Waskiewicz A.J., Flynn A., Proud C.G., Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1997;1909-1920.
29. Mclaughlin M.M., Kumar S., McDonnell P.C., Van Horn S., Lee J.C., Livi G.P., Young P.R. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J. Biol. Chem. 271:1996;8488-8492.
30. New L., Jiang Y., Zhao M., Liu K., Zhu W., Flood L.J., Kato Y., Parry G.C., Han J. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 17:1998;3372-3384.
31. McLaughlin M.M., Kumar S., McDonnell P.C., Van Horn S., Lee J.C., Livi G.P., Young P.R. Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J. Biol. Chem. 271:1996;8488-8492.
32. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:1998;4426-4441.
33. Li B., Tournier C., Davis R.J., Flavell R.A. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18:1999;420-432.
34. Chow C.-W., Rincón M., Cavanagh J., Dickens M., Davis R.J. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science. 278:1997;1638-1641.
35. Fink P.J., Bevan M.J. Positive selection of thymocytes. Adv. Immunol. 59:1995;99-133.
36. Kisielow P., von Boehmer H. Development and selection of T cells facts and puzzles . Adv. Immunol. 58:1995;87-209.
37. Nossal G.J.V. Negative selection of lymphocytes. Cell. 76:1994;229-239.
38. Crompton T., Gilmour K.C., Owen M.J. The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. Cell. 86:1996;243-251.
39. Alberola-Ila J., Forbush K.A., Seger R., Krebs E.G., Perlmutter R.M. Selective requirement for MAP kinase activation in thymocytes differentiation. Nature. 373:1995;620-623.
40. Alberola-Ila J., Hogquist K.A., Swan K.A., Bevan M.J., Perlmutter R.M. Positive and negative selection invoke distinct signaling pathways. J. Exp. Med. 184:1996;9-18.
41. Swan K.A., Alberola-Ila J., Gross J.A., Appleby M.W., Forbush K.A., Thomas J.F., Perlmutter R.M. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J. 14:1995;276-285.
42. + thymocytes. Proc. Natl. Acad. Sci. USA. 93:1996;4683-4687.
43. O'Shea C.C., Crompton T., Rosewell I.R., Hayday A.C., Owen M.J. Raf regulates positive selection. Eur. J. Immunol. 26:1996;2350-2355.
44. + thymocytes. J. Exp. Med. 188:1998;1817-1830.
45. Yang D.D., Dong C., Wysk M., Whitmarsh A.J., Davis R.J., Flavell R.A. Defective T cell differentiation in the absence of Jnk1. Science. 282:1998;2092-2095.
46. + T cells to Th1 cells requires MAP kinase JNK2. Immunity. 7:1998;575-585.
47. Nishina H., Fischer K.D., Radvanyl L., Shahinian A., Haken R., Rubie E.A., Bernstein A., Mak T.W., Woodgett J.R., Penninger J.M. Stress-signalling kinase Sek 1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature. 385:1997;350-353.
48. Swat W., Fujikawa K., Ganiatsas S., Yang D.D., Xavier R.J., Harris N.L., Davidson L., Ferrini R., Davis R.J., Labow M.A., Flavell R.A., Zon L.I., Alt F.W. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for T lymphocyte development. Immunity. 8:1998;625-634.
49. Rincón M., Flavell R.A. AP-1 transcriptional activity requires both T cell receptor-mediated and costimulatory signals in primary T lymphocytes. EMBO J. 13:1994;4370-4381.
50. Rincón M., Flavell R.A. Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells. Mol. Cell. Biol. 16:1996;1074-1084.
51. Rao J., Luo C., Hogan P.G. Transcription factors of the NFAT family. Ann. Rev. Immunol. 15:1997;707-748.
52. Oukka M., Ho I.-C., de la Brousse F.C., Hoey T., Grusby M.J., Glimcher L.H. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity. 9:1998;295-304.
53. Clipstone N.A., Crabtree G.R. Identification of calceniurin as a key signalling enzyme in T cell activation. Nature. 357:1992;695-697.
54. + signals and immunosuppression. Nature 383:837-840; 1996.
55. Flanagan W.F., Corthesy B., Bram R.J., Crabtree G.R. Nuclear association of a T cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 352:1991;803-807.
56. Ho S.N., Thomas D.J., Timmerman L.A., Li X., Francke U., Crabtree G.R. NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. J. Biol. Chem. 270:1995;19808-19907.
57. Hoey T., Sun Y.-L., Williamson K., Xiang X. Isolation of two new members of the NFAT gene family and functional characterization of the NFAT proteins. Immunity. 2:1995;461-472.
58. Masuda E.S., Naito Y., Tokumitsu H., Campbell D., Saito F., Hannum C., Arai K.-I., Arai N. NFATx, a novel member of the nuclear factor of activated-T cells family that is predominantly expressed in thymus. Mol. Cell. Biol. 15:1995;2697-2707.
59. McCaffrey P.G., Luo C., Kerpolla T.K., Jain J., Badalian T.M., Ho A.M., Burgeon E., Lane W.S., Lambert J.N., Curran T., Verdine G.L., Rao A., Hogan P.G. Isolation of cyclosporin-sensitive T cell transcription factor NFATp. Science. 262:1993;750-754.
60. Northrop J.P., Ho S.N., Chen L., Thomas D.J., Nolan G.P., Admon A., Crabtree G.R. NF-AT components define a family of transcription factors targeted in T cell activation. Nature. 369:1994;497-502.
61. Sugawara T., Moriguchi T., Nishida E., Takahama Y. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity. 9:1998;565-574.
62. Mueller D.L., Jenkins M.K., Schwartz R.H. Clonal expansion vs. functional clonal inactivation a costimulatory pathway determines the outcome of T cell receptor occupancy . Ann. Rev. Immunol. 7:1989;445-480.
63. Freeman G.J., Freedman A.S., Segil J.M., Lee G., Whitman J.L., Nadler L.M. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:1989;2714-2722.
64. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730.
65. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L., Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 366:1993;76-79.
66. Freeman G.J., Borriello F., Hodes R.J., Reiser H., Gribben J.G., Ng J.W., Kim J., Goldberg J.M., Hathcock K., Laszlo G., Lombard L.A., Wang S., Gray G.S., Nadler L.M., Sharpe A.H. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:1993;2185-2192.
67. Linsley P.S., Ledbetter J.A. The role of the CD28 receptor during T cell responses. Ann. Rev. Immunol. 11:1993;191-212.
68. Paul W.E., Seder R.A. Lymphocyte response and cytokines. Cell. 76:1994;241-251.
69. + T cell responses the alternative approaches . Ann. Rev. Immunol. 15:1997;297-322.
70. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
71. Le Gros G., Ben-Sasson S.Z., Seder R., Finkelman F.D., Paul W.E. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells . J. Exp. Med. 172:1990;921-929.
72. + T cells to enhance priming for IFNγ production and diminish IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:1993;10188-10192.
73. Swain S.L., Weinberg A.D., English M., Huston G. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:1990;3796-3806.
74. + T cells. J. Exp. Med. 185:1997;461-469.
75. Badger A.M., Bradbeer J.N., Votta B., Lee J.C., Adams J.L., Griswold D.E. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1996;1453-1461.
76. Griswold D.E., Hillegass L.M., Neunier P.C., DiMartino M.J., Hanna N. Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthritis Rheumatol. 31:1988;1406-1412.
77. Lee J.C., Badger A.M., Griswold D.E., Dunnington D., Trunech A., Votta B., White J.R., Young P.R., Bender P.E. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann. NY Acad. Sci. 696:1993;149-170.
78. Reddy M.P., Webb E.F., Cassat D., Maley D., Lee J.C., Griswold D.E., Truneh A. Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitive reactions without affecting T-dependent immune responses. Int. J. Immunopharmacol. 16:1994;795-804.
79. Rincón M., Enslen H., Raingeaud J., Recht M., Zapton T., Su M.S.-S., Penix L.A., Davis R.J., Flavell R.A. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:1998;2817-2829.
80. Lu H.T., Yang D.D., Wysk M., Gatti E., Mellman I., Davis R.J., Flavell R.A. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18:1999;1845-1857.
81. 4+ T cells to effector Th1 and Th2 cells. Genes Funct. 1:1997;51-68.
82. Sabapathy K., Hu Y., Kallunki T., Schreiber M., David J.-P., Jochum W., Wagner E.F., Karin M. JNK2 is required for efficient T cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9:1999;116-125.
83. Ranger A.M., Hodge M.R., Gravallese E.M., Oukka M., Davidson L., Alt F.W., de la Brousse F.C., Hoey T., Grusby M., Glimcher L.H. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity. 8:1998;125-134.
84. Yoshida H., Nishina H., Takimoto H., Marengére L.E.M., Wakeham A.C., Bouchard D., Kong Y.-Y., Ohteki T., Shahinian A., Bachmann M., Ohashi P.S., Penninger J.M., Crabtree G.R., Mak T.W. The transcription factor NF-ATc1 regulates lymphocytes prolipheration and Th2 cytokine production. Immunity. 8:1998;115-124.
85. Yamashita M., Kimura M., Kubo M., Shimizu C., Tada T., Perlmutter R.M., Nakayama T. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. USA. 96:1999;1024-1029.
86. 2-terminal kinase (Jnk) gene expression during T cell activation. J. Exp. Med. 191:2000;139-145.
87. Millet, I.; Phillips, R.; Sherwin, R. S.; Ghosh, S.; Voll, R. E.; Flavell, R. A.; Vignery, A.; Rincón, M. Inhibition of NF-κB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J. Biol. Chem. In press; 2000.
88. Diehl N., Enslen H., Fortner K.A., Stetson N., Charland C., Flavell R.A., Davis R.J., Rincón M. Activation of the p38 MAP kinase pathway arrests in vivo thymocyte differentiation and cell cycle progression. J. Exp. Med. 191:2000;321-334.
89. Merritt C., Enslen H., Diehl N., Conze D., Davis R.J., Rincón M. Activation of p38 MAP kinase in vivo selectively induces apoptosis of CD8+, but not CD4+ T cells. Mol. Cell. Biol. 20:2000;936-946.